Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 611

1.

Fatal pulmonary microthrombi during surgical therapy for end-stage heart failure: possible association with antifibrinolytic therapy.

Cooper JR Jr, Abrams J, Frazier OH, Radovancevic R, Radovancevic B, Bracey AW, Kindo MJ, Gregoric ID.

J Thorac Cardiovasc Surg. 2006 May;131(5):963-8.

2.

Perioperative renal outcome in cardiac surgical patients with preoperative renal dysfunction: aprotinin versus epsilon aminocaproic acid.

Maslow AD, Chaudrey A, Bert A, Schwartz C, Singh A.

J Cardiothorac Vasc Anesth. 2008 Feb;22(1):6-15. doi: 10.1053/j.jvca.2007.07.017.

PMID:
18249324
3.

Selected ventriculoplasty for idiopathic dilated cardiomyopathy with advanced congestive heart failure: midterm results and risk analysis.

Suma H, Tanabe H, Uejima T, Suzuki S, Horii T, Isomura T.

Eur J Cardiothorac Surg. 2007 Dec;32(6):912-6.

PMID:
17964180
4.

Left ventricle volume affects the result of mitral valve surgery for idiopathic dilated cardiomyopathy to treat congestive heart failure.

Horii T, Suma H, Isomura T, Nomura F, Hoshino J.

Ann Thorac Surg. 2006 Oct;82(4):1349-54; discussion 1354-5.

PMID:
16996932
5.

Surgical ventricular restoration for advanced congestive heart failure: should pulmonary hypertension be a contraindication?

Patel ND, Williams JA, Nwakanma LU, Waldron MM, Bluemke DA, Conte JV.

Ann Thorac Surg. 2006 Sep;82(3):879-88; discussion 888.

PMID:
16928501
6.

Tranexamic acid and aprotinin in primary cardiac operations: an analysis of 220 cardiac surgical patients treated with tranexamic acid or aprotinin.

Dietrich W, Spannagl M, Boehm J, Hauner K, Braun S, Schuster T, Busley R.

Anesth Analg. 2008 Nov;107(5):1469-78. doi: 10.1213/ane.0b013e318182252b.

PMID:
18931201
7.

The risks of aprotinin and tranexamic acid in cardiac surgery: a one-year follow-up of 1188 consecutive patients.

Martin K, Wiesner G, Breuer T, Lange R, Tassani P.

Anesth Analg. 2008 Dec;107(6):1783-90. doi: 10.1213/ane.0b013e318184bc20.

PMID:
19020118
8.

Increased incidence of acute kidney injury with aprotinin use during cardiac surgery detected with urinary NGAL.

Wagener G, Gubitosa G, Wang S, Borregaard N, Kim M, Lee HT.

Am J Nephrol. 2008;28(4):576-82. doi: 10.1159/000115973.

PMID:
18264006
9.

Noncardiac surgery in long-term implantable left ventricular assist-device recipients.

Goldstein DJ, Mullis SL, Delphin ES, el-Amir N, Ashton RC Jr, Gardocki M, Jordan DA, Catanese KA, Levin HR, Rose EA, et al.

Ann Surg. 1995 Aug;222(2):203-7.

10.

Partial left ventriculectomy: preoperative risk factors for perioperative mortality.

Bestetti RB, Moreira-Neto F, Brasil JC, Bombonato R, Sgarbieri RN, Haddad J.

Int J Cardiol. 1998 Dec 1;67(2):143-6.

PMID:
9891947
11.

Effect of sildenafil on pulmonary artery pressure, systemic pressure, and nitric oxide utilization in patients with left ventricular assist devices.

Klodell CT Jr, Morey TE, Lobato EB, Aranda JM Jr, Staples ED, Schofield RS, Hess PJ, Martin TD, Beaver TM.

Ann Thorac Surg. 2007 Jan;83(1):68-71; discussion 71.

PMID:
17184632
12.

Circulatory support with right ventricular assist device and intra-aortic balloon counterpulsation in patient with right ventricle failure after pulmonary embolectomy.

Lango R, Kowalik MM, Klajbor K, Rogowski J.

Interact Cardiovasc Thorac Surg. 2008 Aug;7(4):643-5. doi: 10.1510/icvts.2008.175877.

PMID:
18400825
13.

Midterm experience with the Jarvik 2000 axial flow left ventricular assist device.

Haj-Yahia S, Birks EJ, Rogers P, Bowles C, Hipkins M, George R, Amrani M, Petrou M, Pepper J, Dreyfus G, Khaghani A.

J Thorac Cardiovasc Surg. 2007 Jul;134(1):199-203.

14.

[Surgical therapy of end-stage heart failure. State of the art 2006].

Klotz S, Loeher A, Drees G, Scheld HH.

Herz. 2006 Aug;31(5):445-54. Review. German.

PMID:
16944064
15.

Intraaortic balloon pumping in patients with right ventricular insufficiency after cardiac surgery: parameters to predict failure of IABP Support.

Boeken U, Feindt P, Litmathe J, Kurt M, Gams E.

Thorac Cardiovasc Surg. 2009 Sep;57(6):324-8. doi: 10.1055/s-0029-1185766.

PMID:
19707972
16.

Improved survival and decreasing incidence of adverse events with the HeartMate II left ventricular assist device as bridge-to-transplant therapy.

John R, Kamdar F, Liao K, Colvin-Adams M, Boyle A, Joyce L.

Ann Thorac Surg. 2008 Oct;86(4):1227-34; discussion 1234-5. doi: 10.1016/j.athoracsur.2008.06.030.

PMID:
18805167
17.

Left ventricular assist device support of medically unresponsive pulmonary hypertension and aortic insufficiency.

Adamson RM, Dembitsky WP, Jaski BE, Daily PO, Moreno R, Kim JC, Sono J, Akasaka T, Hoagland PM, Gordon JB.

ASAIO J. 1997 Jul-Aug;43(4):365-9.

PMID:
9242955
18.

Initial experience with the AbioCor implantable replacement heart system.

Dowling RD, Gray LA Jr, Etoch SW, Laks H, Marelli D, Samuels L, Entwistle J, Couper G, Vlahakes GJ, Frazier OH.

J Thorac Cardiovasc Surg. 2004 Jan;127(1):131-41.

19.

Seizures after open heart surgery: comparison of ε-aminocaproic acid and tranexamic acid.

Martin K, Knorr J, Breuer T, Gertler R, Macguill M, Lange R, Tassani P, Wiesner G.

J Cardiothorac Vasc Anesth. 2011 Feb;25(1):20-5. doi: 10.1053/j.jvca.2010.10.007.

PMID:
21272777
20.

Left ventricular assist devices decrease fixed pulmonary hypertension in cardiac transplant candidates.

Zimpfer D, Zrunek P, Roethy W, Czerny M, Schima H, Huber L, Grimm M, Rajek A, Wolner E, Wieselthaler G.

J Thorac Cardiovasc Surg. 2007 Mar;133(3):689-95.

Supplemental Content

Support Center